NICE is set to update its guidance on treatments for Alzheimer´s disease, widening access to four drugs. The draft guidance …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

